Series B funding round for Pelage Pharmaceuticals raising $120M in October 2025
Series B funding round for Pelage Pharmaceuticals raising $120M in October 2025
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
GVLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$150.8M
Top Valuation
-
Pelage Pharmaceuticals raised $120M in a Series B round.
The round was announced on 10/01/25.
The round was led by ARCH Venture Partners, Cathy Friedman.